Literature DB >> 19228814

M. bovis BCG induced expression of COX-2 involves nitric oxide-dependent and -independent signaling pathways.

Kushagra Bansal1, Yeddula Narayana, Shripad A Patil, Kithiganahalli N Balaji.   

Abstract

In a multifaceted immunity to mycobacterial infection, induced expression of cyclooxygenase-2 (COX-2) by Mycobacterium bovis bacillus Calmette-Guerin (BCG) may act as an important influencing factor for the effective host immunity. We here demonstrate that M. bovis BCG-triggered TLR2-dependent signaling leads to COX-2 and PGE2 expression in vitro in macrophages and in vivo in mice. Further, the presence of PGE2 could be demonstrated in sera or cerebrospinal fluid of tuberculosis patients. The induced COX-2 expression in macrophages is dependent on NF-kappaB activation, which is mediated by inducible NO synthase (iNOS)/NO-dependent participation of the members of Notch1-PI-3K signaling cascades as well as iNOS-independent activation of ERK1/2 and p38 MAPKs. Inhibition of iNOS activity abrogated the M. bovis BCG ability to trigger the generation of Notch1 intracellular domain (NICD), a marker for Notch1 signaling activation, as well as activation of the PI-3K signaling cascade. On the contrary, treatment of macrophages with 3-morpholinosydnonimine, a NO donor, resulted in a rapid increase in generation of NICD, activation of PI-3K pathway, as well as the expression of COX-2. Stable expression of NICD in RAW 264.7 macrophages resulted in augmented expression of COX-2. Further, signaling perturbations suggested the involvement of the cross-talk of Notch1 with members with the PI-3K signaling cascade. These results implicate the dichotomous nature of TLR2 signaling during M. bovis BCG-triggered expression of COX-2. In this perspective, we propose the involvement of iNOS/NO as one of the obligatory, early, proximal signaling events during M. bovis BCG-induced COX-2 expression in macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228814     DOI: 10.1189/jlb.0908561

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  24 in total

1.  Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation.

Authors:  Kushagra Bansal; Kithiganahalli N Balaji
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

2.  Autoamplification of Notch signaling in macrophages by TLR-induced and RBP-J-dependent induction of Jagged1.

Authors:  Julia Foldi; Allen Y Chung; Haixia Xu; Jimmy Zhu; Hasina H Outtz; Jan Kitajewski; Yueming Li; Xiaoyu Hu; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

3.  Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.

Authors:  Praveen Prakhar; Sahana Holla; Devram Sampat Ghorpade; Martine Gilleron; Germain Puzo; Vibha Udupa; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2015-09-21       Impact factor: 5.157

4.  Pathogen-specific TLR2 protein activation programs macrophages to induce Wnt-beta-catenin signaling.

Authors:  Kushagra Bansal; Jamma Trinath; Dipshikha Chakravortty; Shripad A Patil; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

5.  Cooperative regulation of NOTCH1 protein-phosphatidylinositol 3-kinase (PI3K) signaling by NOD1, NOD2, and TLR2 receptors renders enhanced refractoriness to transforming growth factor-beta (TGF-beta)- or cytotoxic T-lymphocyte antigen 4 (CTLA-4)-mediated impairment of human dendritic cell maturation.

Authors:  Devram Sampat Ghorpade; Srini V Kaveri; Jagadeesh Bayry; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

6.  Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection.

Authors:  Matthew P Wood; Lianna F Wood; Megan Templeton; Bridget Fisher; Adriana Lippy; Chloe I Jones; Cecilia S Lindestam Arlehamn; Alessandro Sette; James T Fuller; Patience Murapa; Heather B Jaspan; Deborah H Fuller; Donald L Sodora
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

7.  Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection.

Authors:  Francesca Conradie; Andrea S Foulkes; Prudence Ive; Xiangfan Yin; Katerina Roussos; Deborah K Glencross; Denise Lawrie; Wendy Stevens; Luis J Montaner; Ian Sanne; Livio Azzoni
Journal:  J Acquir Immune Defic Syndr       Date:  2011-11-01       Impact factor: 3.731

8.  Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responses.

Authors:  Kushagra Bansal; Akhauri Yash Sinha; Devram Sampat Ghorpade; Shambhuprasad Kotresh Togarsimalemath; Shripad A Patil; Srini V Kaveri; Kithiganahalli Narayanaswamy Balaji; Jagadeesh Bayry
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

9.  The multifunctional PE_PGRS11 protein from Mycobacterium tuberculosis plays a role in regulating resistance to oxidative stress.

Authors:  Rashmi Chaturvedi; Kushagra Bansal; Yeddula Narayana; Nisha Kapoor; Namineni Sukumar; Shambhuprasad Kotresh Togarsimalemath; Nagasuma Chandra; Saurabh Mishra; Parthasarathi Ajitkumar; Beenu Joshi; Vishwa Mohan Katoch; Shripad A Patil; Kithiganahalli N Balaji
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

10.  Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.

Authors:  Devram Sampat Ghorpade; Sahana Holla; Akhauri Yash Sinha; Senthil Kumar Alagesan; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2013-06-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.